Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Simulations Plus, Inc. - Common Stock (NQ:SLP)

14.76 -0.95 (-6.05%)
Official Closing Price Updated: 4:15 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Simulations Plus, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Simulations An Attractive Vehicle For Investors Seeking Exposure To Biotech Innovation Themes, Analyst Says
Oppenheimer analyst Francois Brisebois reiterated an Outperform rating on Simulations Plus, Inc. (NASDAQ: SLP) with a  
Via Benzinga
Costco, AZZ And 3 Stocks To Watch Heading Into Friday
With U.S. stock futures trading slightly lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Recap: Simulations Plus Q3 Earnings
 
Via Benzinga
Simulations Plus Reports Third Quarter Fiscal 2023 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus's Earnings: A Preview
 
Via Benzinga
Simulations Plus Announces Third Quarter Fiscal Year 2023 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
Preview: Simulations Plus's Earnings
 
Via Benzinga
Simulations Plus Is High-Growth Investment Opportunity In The Wake Of Immunetrics Acquisition: Analyst
Oppenheimer analyst Francois Brisebois reiterated an Outperform rating on the shares of Simulations Plus, Inc. (NASDAQ: SLP),  
Via Benzinga
Simulations Plus Acquires Immunetrics to Expand its Immunology and Oncology Drug Development Capabilities
From Simulations Plus, Inc.
Via Business Wire
7 Stocks Under $50 to Buy (and Never Sell)
Although you usually get what you pay for, these best affordable stocks to invest in punch above their weight class. 
Via InvestorPlace
Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes
From Simulations Plus, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023
 
Via Benzinga
Roblox And 3 Other Stocks Insiders Are Selling
The Nasdaq Composite closed sharply higher on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Reports Second Quarter Fiscal 2023 Financial Results
From Simulations Plus, Inc.
Via Business Wire
MIDD+ 2023 Panelists Discuss How to Increase Gender Equity for Women in Science
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Present at Sidoti March Small-Cap Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Enters Partnership to Apply AI/ML Technologies to Design Novel Compounds
From Simulations Plus, Inc.
Via Business Wire
Lixoft Adds New Data Formatting and Reporting Modules to MonolixSuite™ in Version 2023R1
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Present at Oppenheimer 33rd Annual Healthcare Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Present at Raymond James 44th Annual Institutional Investors Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus and Global Agrochemicals Leader to Collaborate on Machine Learning Models
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases Redesigned NAFLDsym® QSP Software Tool
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Executes $20 Million Accelerated Share Repurchase Agreement
From Simulations Plus, Inc.
Via Business Wire
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 63 companies set new 52-week lows. 
Via Benzinga
Constellation Brands, Walgreens, RPM International And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.